TIG Advisors LLC’s SpringWorks Therapeutics SWTX Stock Holding History

TIG Advisors LLC’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,200	Closed	-$671K	–	75
2025 Q1	$671K	Buy	+15,200	New	+$700K	0.04%	54

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TIG Advisors LLC's SWTX Position: Q3 2025 in Review

TIG Advisors LLC sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 2,611,074 shares — an estimated $123M sold.

TIG Advisors LLC first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $123M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

TIG Advisors LLC reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
TIG Advisors LLC sold 2,611,074 SpringWorks Therapeutics shares in Q3 2025, an estimated $123M.
TIG Advisors LLC first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
TIG Advisors LLC's SpringWorks Therapeutics position peaked at $123M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on TIG Advisors LLC's 13F filing for Q3 2025, filed 14 Nov 2025.